{"paper_id":"c9ce4946-3b23-4ceb-a835-19cc3095ff7f","body_text":"International Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 1 \n \nEndometriosis Symptoms, Etiology, and Effects \nof Lifestyle Changes and Food Habits: A \nDetailed Literature Review  \n \nDr Manju Thomas \n \nDepartment of Clinical Pharmacology, St Joseph University college of Health and Allied sciences,  \nDares salaam, Tanzania \n \nAbstract \nEndometriosis is a chronic gynecological disorder characterized by the presence of endometrial-like tissue \noutside the uterine cavity. It affects approximately 10–15% of women of reproductive age and is associated \nwith pelvic pain, dysmenorrhea, dyspareunia, infertility, and reduced quality of life. The pathogenesis of \nendometriosis is complex and multifactorial, involving hormonal imbalances, genetic predispositions, \nimmunological dysfunctions, environmental exposures, and epigenetic modifications. Lifesty le factors \nand dietary patterns have emerged as important modulators in the onset and progression of endometriosis. \nThis review aims to synthesize current evidence on the symptoms, etiology, and the role of lifestyle \nmodifications—including physical activi ty, stress management, sleep, smoking, alcohol, and dietary \nhabits—in the prevention and management of endometriosis. The paper highlights both protective and \nrisk-enhancing behaviors and provides perspectives for future interventions. \n \nMethods \nA comprehensive literature search was conducted using PubMed, Scopus, and Web of Science databases \nfor publications between 2000 and 2025. Keywords included endometriosis, dysmenorrhea, etiology, \npathogenesis, lifestyle factors, diet, nutrition, and risk f actors. Both observational and interventional \nstudies were included, with emphasis on systematic reviews, meta -analyses, and well -designed cohort \nstudies. Studies not in English or not directly related to endometriosis were excluded. References were \nlimited to 60 to maintain clarity and avoid redundancy, prioritizing the most relevant and high -quality \nevidence. Citation style followed the Vancouver system. \n \nDefinition of Terms \nEndometriosis: A gynecological condition defined by the presence of functional endometrial -like tissue \noutside the uterine cavity, often leading to pain and infertility. \nDysmenorrhea: Painful menstruation, commonly classified as primary (without pelvic pathology) or \nsecondary (associated with pelvic disease such as endometriosis). \nLifestyle factors: Modifiable behaviors including diet, exercise, smoking, alcohol use, sleep, and stress \nmanagement that influence disease risk and progression. \nChemoprevention: The use of natural or synthetic agents, including dietary components, to inhibit, reverse, \nor slow the development of disease. \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 2 \n \nIntroduction \nEndometriosis is a debilitating disorder with significant medical, social, and economic consequences. \nGlobally, it affects approximately 190 million women and adolescent girls of reproductive age, though \nprevalence varies based on diagnostic methods and population characteristics [1]. Clinical presentation is \nheterogeneous, ranging from asymptomatic cases to severe pelvic pain, infertility, and systemic \nmanifestations [2]. \nThe economic burden of endometriosis is considerable, with costs associated not only with direct medical \ncare but also loss of productivity, absenteeism, and reduced quality of life [3]. Despite advances in \ndiagnostic techniques, including imaging and mini mally invasive surgery, delayed diagnosis remains \ncommon, often extending from 7 to 10 years after symptom onset [4]. \nThe etiology of endometriosis is complex and multifactorial. Several theories —including retrograde \nmenstruation, coelomic metaplasia, stem/progenitor cell involvement, genetic predisposition, immune \ndysfunction, and hormonal imbalances—have been proposed [5,6]. However, none alone can fully explain \nthe heterogeneity of the disease. Lifestyle and environmental factors, particularly diet, exercise, stress, \nsleep, and exposure to endocrine-disrupting chemicals, have been recognized as important contributors to \nrisk and disease progression [7,8]. \nThis review provides an in-depth examination of the clinical features, etiology, and the impact of dietary \nand lifestyle factors on endometriosis, aiming to integrate evidence into actionable insights for both \nprevention and management. \n \nSymptoms and Dysmenorrhea \nThe hallmark symptoms of endometriosis include dysmenorrhea, chronic pelvic pain , dyspareunia, \ndyschezia, and infertility [9]. Dysmenorrhea is particularly significant, often severe and debilitating, and \ntends to worsen over time rather than improve as in primary dysmenorrhea [10]. The pain is typically \ncyclical but may persist throughout the menstrual cycle in advanced cases. \nEndometriosis-related dysmenorrhea is attributed to excessive production of prostaglandins and cytokines \nin ectopic endometrial tissue, leading to uterine hypercontractility, ischemia, and heightened pain \nperception [11]. Chronic inflammation also contribu tes to central sensitization, amplifying pain even in \nthe absence of visible lesions [12]. \nIn addition to dysmenorrhea, other manifestations include fatigue, bloating, gastrointestinal disturbances, \nand urinary symptoms, which further complicate diagnosis [13]. Infertility, affecting up to 50% of women \nwith endometriosis, is associated with pelv ic adhesions, distorted anatomy, and impaired oocyte and \nembryo quality [14]. \nThe impact on quality of life is profound, with significant psychological consequences such as anxiety, \ndepression, and reduced social functioning [15]. Dysmenorrhea remains the most reliable clinical indicator \nof endometriosis and should prompt further di agnostic evaluation when persistent and resistant to \nconventional therapy. \n \nEtiology and Pathogenesis \nThe pathogenesis of endometriosis remains an area of intense investigation, with several interrelated \nmechanisms proposed: \n \n \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 3 \n \nRetrograde Menstruation Theory \nFirst proposed by Sampson in 1927, this theory suggests that viable endometrial fragments flow backward \nthrough the fallopian tubes into the peritoneal cavity during menstruation, where they implant and \nproliferate [16]. While retrograde menstruation occur s in up to 90% of women, only a fraction develop \nendometriosis, indicating that additional factors such as immune dysfunction and genetic predisposition \nplay roles [17]. \n \nCoelomic Metaplasia \nThis theory posits that peritoneal mesothelial cells undergo metaplasia into endometrial -like cells under \nhormonal or inflammatory stimuli. It helps explain rare cases of endometriosis in men receiving estrogen \ntherapy and in women without functional endometrium [18]. \n \nStem/Progenitor Cell Theory \nRecent evidence supports the role of endometrial stem/progenitor cells with high proliferative capacity in \nestablishing ectopic lesions. Bone marrow-derived stem cells may also contribute to lesion formation [19]. \n \nGenetic and Epigenetic Factors \nGenetic susceptibility plays a role, with studies identifying loci associated with endometriosis risk, \nincluding those regulating hormone metabolism and inflammation [20]. Epigenetic modifications, such as \nDNA methylation and histone acetylation, alter gen e expression in endometriotic tissue, promoting \nsurvival and angiogenesis [21]. \n \nHormonal and Immunological Dysregulation \nEndometriotic lesions are estrogen -dependent and resistant to progesterone, resulting in an estrogen -\ndominant, pro-inflammatory environment [22]. Immune dysfunction, including impaired natural killer cell \nactivity and increased macrophage infiltration, facilitates lesion survival and progression [23]. \n \nEnvironmental Exposures \nEndocrine-disrupting chemicals (EDCs), including dioxins, bisphenol A, and phthalates, have been \nimplicated in altering hormone signaling and immune responses, potentially increasing endometriosis risk \n[24]. \nThe multifactorial nature of endometriosis suggests that genetic predisposition interacts with \nenvironmental exposures and lifestyle factors to determine disease onset and severity. \n \nDiet and Nutrition in Endometriosis \nDietary patterns and nutrient intake significantly influence the risk and severity of endometriosis. Nutrition \nmodulates systemic inflammation, oxidative stress, and hormonal balance —all central mechanisms in \nendometriosis pathophysiology. \n \nPro-inflammatory Diets \nDiets rich in red and processed meats, trans fats, and refined carbohydrates are associated with increased \nrisk and severity of endometriosis. Red meat consumption has been linked to elevated estrogen levels, \nwhile trans fats promote systemic inflammation [25]. \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 4 \n \nProtective Dietary Components \nFruits, vegetables, whole grains, and omega-3 fatty acids exert protective effects. High intake of fruits and \ngreen vegetables is associated with reduced risk, likely due to their antioxidant and anti -inflammatory \nproperties [26]. Omega-3 fatty acids, found in fatty fish and flaxseed, reduce prostaglandin synthesis and \nmay alleviate dysmenorrhea [27]. \n \nDairy Products and Vitamin D \nThe role of dairy is controversial, though some studies suggest protective effects attributed to calcium, \nvitamin D, and anti -inflammatory properties of certain dairy proteins [28]. Vitamin D, through its \nimmunomodulatory role, has been associated with reduced risk and symptom relief [29]. \n \nMicronutrients \nAntioxidant vitamins such as vitamins C and E, as well as trace elements like zinc and selenium, counter \noxidative stress and have been linked to improved outcomes [30]. \n \nCaffeine and Alcohol \nHigh caffeine and alcohol consumption may exacerbate endometriosis by altering estrogen metabolism, \nthough findings remain inconsistent [31]. \n \nDietary Patterns \nAdherence to Mediterranean dietary patterns—rich in fruits, vegetables, fish, legumes, and olive oil—has \nbeen associated with lower risk and improved symptom management [32]. Conversely, Western dietary \npatterns correlate with higher disease prevalence [33]. \nOverall, dietary interventions represent a promising, non -invasive strategy to complement conventional \ntreatments and improve quality of life in women with endometriosis. \n \nLifestyle Factors \nLifestyle behaviours play a crucial role in modulating endometriosis risk, symptom severity, and overall \nquality of life. Modifiable factors—including physical activity, smoking, alcohol intake, stress, and sleep \npatterns—interact with hormonal, immune, and metabolic pathways that underlie the disease process. \n \nPhysical Activity \nRegular physical activity exerts beneficial effects by lowering estrogen levels, enhancing immune \nsurveillance, and reducing systemic inflammation [34]. Exercise also improves pelvic blood flow and \nreduces oxidative stress, which may alleviate dysmenorrhea and chronic pelvic pain [35]. Cohort studies \nhave shown that women engaging in moderate -to-vigorous physical activity experience reduced risk of \nendometriosis diagnosis and milder symptoms [36]. However, evidence remains mixed, with some studies \nreporting no significant association, potentially due to variations in exercise intensity, frequency, and \nindividual susceptibility [37]. \n \nSmoking \nCigarette smoking has complex and somewhat contradictory effects. While smoking is generally \nassociated with reduced estrogen levels, it also induces systemic inflammation, oxidative stress, and \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 5 \n \nvascular dysfunction, which may exacerbate symptoms [38]. Meta -analyses suggest that smoking does \nnot consistently reduce endometriosis risk, and in some cases, it may worsen pelvic pain and disease \nprogression [39]. \n \nAlcohol Consumption \nAlcohol intake has been linked to increased risk of endometriosis in multiple observational studies [40]. \nAlcohol disrupts estrogen metabolism, raises circulating estradiol levels, and promotes oxidative stress \n[41]. Women with endometriosis often report w orsening pelvic pain and dysmenorrhea with regular \nalcohol consumption [42]. \n \nStress and Psychological Health \nChronic stress amplifies hypothalamic-pituitary-adrenal (HPA) axis activity, increasing cortisol secretion \nand impairing immune function [43]. Stress -induced inflammatory pathways may worsen pain and \ncontribute to central sensitization [44]. Women with end ometriosis are at elevated risk for anxiety and \ndepression, conditions that further exacerbate pain perception and reduce treatment adherence [45]. \nInterventions such as mindfulness, cognitive-behavioural therapy, and yoga have demonstrated benefit in \nsymptom management [46]. \n \nSleep Patterns \nSleep disturbances are highly prevalent in women with endometriosis, often related to pain, hormonal \nimbalances, and psychological distress [47]. Poor sleep exacerbates systemic inflammation, impairs pain \nregulation, and worsens fatigue [48]. Studies suggest that improving sleep hygiene and treating comorbid \ninsomnia can significantly reduce pain severity and improve quality of life [49]. \n \nObesity and Body Mass Index (BMI) \nAlthough endometriosis often occurs in women with normal BMI, obesity may contribute to systemic \ninflammation, altered estrogen metabolism, and poorer outcomes [50]. Weight management through \nbalanced diet and physical activity may improve symptom control and treatment response. \n \nDiscussion \nThe interplay between genetic, hormonal, immunological, and environmental factors makes endometriosis \na highly complex disease. Lifestyle factors —including diet, exercise, stress management, and sleep —\nemerge as critical, modifiable determinants that influence disease onset, symptom severity, and quality of \nlife. Evidence suggests that anti -inflammatory diets, regular physical activity, stress reduction, and \nadequate sleep can improve clinical outcomes, whereas smoking, alcohol consumption, and sedentary \nbehaviour worsen symptoms. \nThe heterogeneity of findings in existing literature highlights methodological limitations, including \nreliance on self-reported data, small sample sizes, and varying diagnostic criteria. Moreover, cultural and \nsocioeconomic factors affect lifestyle behaviours and access to healthcare, underscoring the need for more \ndiverse and representative research cohorts. \n \nFuture Directions \nFuture research should focus on: \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 6 \n \n1. Longitudinal Cohort Studies: To clarify causal links between lifestyle factors and endometriosis risk. \n2. Randomized Controlled Trials (RCTs): To assess the efficacy of dietary and lifestyle interventions \nin symptom management. \n3. Integrative Approaches : Combining conventional therapies with lifestyle modification, nutrition, \nand mind-body practices. \n4. Personalized Medicine : Identifying subgroups of patients who may benefit most from specific \nlifestyle interventions based on genetic and epigenetic profiles. \n5. Public Health Strategies : Awareness campaigns to educate women and healthcare providers about \nthe role of lifestyle in prevention and management. \n \nConclusion \nEndometriosis remains a major public health concern, significantly impairing women’s reproductive, \npsychological, and social well -being. While its etiology is multifactorial and not fully understood, \nevidence increasingly points to the role of modifiable l ifestyle and dietary factors in influencing disease \nrisk and progression. Adoption of anti-inflammatory diets, engagement in regular physical activity, stress \nmanagement, quality sleep, and avoidance of alcohol and smoking appear beneficial. These strategi es \nrepresent low -cost, non -invasive adjuncts to conventional medical and surgical therapies. Future \nintegrative approaches that emphasize patient education and individualized lifestyle interventions may \nreduce disease burden and improve long-term outcomes. \n \nReferences \n1. Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nat Rev Dis \nPrimers. 2018;4:9. \n2. Johnson NP, Hummelshoj L; World Endometriosis Society Montpellier Consortium. Consensus on \ncurrent management of endometriosis. Hum Reprod. 2013;28(6):1552-68. \n3. Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389-98. \n4. Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, Diagnosis and Clinical Management. \nCurr Obstet Gynecol Rep. 2017;6:34-41. \n5. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management \nof endometriosis. Nat Rev Endocrinol. 2019;15(11):666-82. \n6. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. \n2012;98(3):511-9. \n7. Saunders PTK, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. \n2021;184(11):2807-24. \n8. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev \nEndocrinol. 2014;10(5):261-75. \n9. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for \nthe diagnosis and treatment of endometriosis. Hum Reprod. 2005;20(10):2698-704. \n10. Dunselman GAJ, Vermeulen N, Becker C, Calhaz -Jorge C, D’Hooghe T, De Bie B, et al. ESHRE \nguideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400-12. \n11. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of \nlaparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am \nJ Epidemiol. 2004;160(8):784-96. \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 7 \n \n12. Kvaskoff M, Mahamat-Saleh Y, Farland LV, Shigesi N, Terry KL, Harris HR, et al. Endometriosis \nand cancer: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(2):393-420. \n13. Nnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et \nal. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten \ncountries. Fertil Steril. 2011;96(2):366-73.e8. \n14. Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women’s lives: a \nqualitative study. BMC Womens Health. 2014;14:123. \n15. Ballard KD, Lowton K, Wright JT. What’s the delay? A qualitative study of women’s experiences of \nreaching a diagnosis of endometriosis. Fertil Steril. 2006;86(5):1296-301. \n16. Vercellini P, Meana M, Hummelshoj L, Somigliana E, Viganò P, Fedele L. Priorities for endometriosis \nresearch: a proposed focus on deep dyspareunia. Reprod Sci. 2011;18(2):114-8. \n17. Facchin F, Barbara G, Saita E, Mosconi P, Roberto A, Fedele L, et al. Impact of endometriosis on \nquality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol. \n2015;36(4):135-41. \n18. Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, et al. The social and psychological \nimpact of endometriosis on women’s lives: a critical narrative review. Hum Reprod Update. \n2013;19(6):625-39. \n19. Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the \nUnited States: national estimates from a cross -sectional survey of 59,411 women. Gynecol Obstet \nInvest. 2017;82(5):453-61. \n20. Shafrir AL, Farland LV, Shah DK, Harris HR, Kvaskoff M, Zondervan K, et al. Risk for and \nconsequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. \n2018;51:1-15. \n21. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. High prevalence \nof endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. \n2009;92(1):68-74. \n22. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268-79. \n23. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the \nperitoneal cavity. Am J Obstet Gynecol. 1927;14:422-69. \n24. Brosens I, Benagiano G. Is neonatal uterine bleeding involved in the pathogenesis of endometriosis as \na source of stem cells? Fertil Steril. 2013;100(3):622-3. \n25. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, et al. Gene expression analysis \nof endometrium reveals progesterone resistance and candidate susceptibility genes in women with \nendometriosis. Endocrinology. 2007;148(8):3814-26. \n26. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587-607. \n27. Smolarz B, Szyłło K, Romanowicz H. Endometriosis: Epidemiology, classification, pathogenesis, \ntreatment and genetics. (Review). Oncol Lett. 2021;22(6):854. \n28. Hapangama DK, Kamal AM, Bulmer JN. Estrogen receptor β: the guardian of the endometrium. Hum \nReprod Update. 2015;21(2):174-93. \n29. Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN. Pathogenesis of endometriosis: interaction \nbetween endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol. 2018;50:50-60. \n30. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244-56. \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 8 \n \n31. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological \nfactors. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):177-200. \n32. Harris HR, Costenbader KH, Mu F, Kvaskoff M, Malspeis S, Karlson EW, et al. Endometriosis and \nthe risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis. \n2016;75(7):1279-84. \n33. Vitonis AF, Vincent K, Rahmioglu N, Fassbender A, Buck Louis GM, Hummelshoj L, et al. World \nEndometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: \nII. Clinical and covariate phenotype data collection in endometriosis research. Fertil Steril. \n2014;102(5):1223-32. \n34. Shan K, Lian F, Zhuo L, Wang Y, Guo J, Zhang R. Dietary patterns and endometriosis risk: a \nsystematic review and meta-analysis. Medicine (Baltimore). 2021;100(22):e26129. \n35. Parazzini F, Viganò P, Candiani M, Fedele L. Diet and endometriosis risk: a literature review. Reprod \nBiomed Online. 2013;26(4):323-36. \n36. Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and \nvitamin D intake and endometriosis risk. Am J Epidemiol. 2013;177(5):420-30. \n37. Trabert B, Peters U, De Roos AJ, Scholes D, Holt VL. Diet and risk of endometriosis in a population-\nbased case-control study. Fertil Steril. 2011;96(2):366-73. \n38. Yamamoto A, Harris HR, Vitonis AF, Chavarro JE, Missmer SA. A prospective cohort study of meat \nand fish consumption and endometriosis risk. Am J Obstet Gynecol. 2018;219(2):178.e1-178.e10. \n39. Nodler JL, DiBenedetti DB, Carr KR, Sikes CR, Muramoto ML. Dietary supplement use and risk of \nendometriosis in women: a systematic review. Reprod Biomed Online. 2020;41(1):317-28. \n40. Nirgianakis K, Gasparri ML, Radan AP, Villiger A, McKinnon B, Mosimann B, et al. Nutritional and \ndietary interventions in endometriosis: a systematic review. Reprod Biomed Online. 2022;44(5):779-\n804. \n41. Santanam N, Kavtaradze N, Murphy A, Dominguez C, Parthasarathy S. Antioxidant supplementation \nreduces endometriosis-related pelvic pain in humans. Transl Res. 2013;161(3):189-95. \n42. Chiaffarino F, Parazzini F, Bertuccio P, Chatenoud L, Ricci E, Bianchi S, et al. Coffee and caffeine \nintake and risk of endometriosis: a meta-analysis. Eur J Nutr. 2014;53(7):1573-9. \n43. Missmer SA, Chavarro JE, Malspeis S, Bertone -Johnson ER, Hornstein MD, Spiegelman D, et al. A \nprospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010;25(6):1528 -\n35. \n44. Hediger ML, Hartnett HJ, Louis GM. Association of endometriosis with body size and figure. Fertil \nSteril. 2005;84(5):1366-74. \n45. Vitonis AF, Baer HJ, Hankinson SE, Laufer MR, Missmer SA. A prospective study of body size during \nchildhood and early adulthood and the incidence of endometriosis. Epidemiology. 2010;21(3):433-9. \n46. Farland LV, Missmer SA, Bijon A, Gusto G, Gelot A, Clavel-Chapelon F, et al. Physical activity and \nendometriosis risk in women with infertility or pain: evidence from the French E3N cohort. Hum \nReprod. 2016;31(2):364-72. \n47. Vitonis AF, Hankinson SE, Hornstein MD, Missmer SA. Adult physical activity and endometriosis \nrisk. Epidemiology. 2010;21(6):911-7. \n48. Yamamoto A, Harris HR, Vitonis AF, Chavarro JE, Missmer SA. A prospective study of alcohol \nconsumption and risk of endometriosis. Am J Obstet Gynecol. 2019;220(3):262.e1-262.e10. \n\n \nInternational Journal for Multidisciplinary Research (IJFMR) \n \nE-ISSN: 2582-2160   ●   Website: www.ijfmr.com       ●   Email: editor@ijfmr.com \n \nIJFMR250557155 Volume 7, Issue 5, September-October 2025 9 \n \n49. Parazzini F, Chiaffarino F, Surace M, Chatenoud L, Cipriani S, Chiantera V, et al. Selected food intake \nand risk of endometriosis. Hum Reprod. 2004;19(8):1755-9. \n50. Vercellini P, Somigliana E, Viganò P, Abbiati A, Barbara G, Crosignani PG. Post -operative \nendometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical \nevidence. Reprod Biomed Online. 2010;21(2):259-65. \n51. Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, et al. Endometriosis. Endocr Rev. \n2019;40(4):1048-79. \n52. Kundu S, Wild RA, Unruh D, Poretsky L. Metabolic aspects of endometriosis: a review. Reprod Sci. \n2021;28(10):2774-84. \n53. Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland LV, et al. Endometriosis: a high -risk \npopulation for major chronic diseases? Hum Reprod Update. 2015;21(4):500-16. \n54. Prescott J, Farland LV, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE, et al. A prospective \ncohort study of endometriosis and subsequent risk of infertility. Hum Reprod. 2016;31(7):1475-82. \n55. Morotti M, Vincent K, Becker CM. Mechanisms of pain in endometriosis. Eur J Obstet Gynecol \nReprod Biol. 2017;209:8-13. \n56. Howard FM. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol \nSurv. 1993;48(6):357-87. \n57. Johnson NP, Hummelshoj L. Consensus on current management of endometriosis. Hum Reprod. \n2013;28(6):1552-68. \n58. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789-99. \n59. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the \nrelationship and implications. Hum Reprod Update. 2011;17(3):327-46. \n60. Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen -progestins and \nprogestins for the management of endometriosis. Fertil Steril. 2016;106(7):1552-71.e2.","source_license":"CC0","license_restricted":false}